Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Understanding Autism: Etiology, Risk Factors & Early Intervention: The Medical Consensus on Autism Origins, Genetic & Prenatal Factors, Debunked Myths, and Early Developmental Support

A developmental pediatrics reference on genetic architecture and heritability, advanced parental age, perinatal factors, the evidence against a vaccine link, developmental surveillance and screening, and early intervention.

Submitted research brief - Submitted to OwieClear; written with an AI assistant - November 2026

Read this first. This document was written outside OwieClear and has not been reviewed by a clinician. We publish it so you can read the source for yourself. It is educational and is not medical advice. Where our own pages disagree with it, follow our pages, which cite their sources, and ask a healthcare professional about anything that affects your care.

What we found that needs correcting

  • This brief is accurate on the science and right about the thing that matters most: autism is not caused by parenting, lifestyle or vaccines, and it is a neurodevelopmental difference rather than a preventable illness. The vaccine section in particular is stated as clearly as it should be. The notes below are one omission that affects how parents read the rest, one genuinely modifiable prenatal factor, and some proportion on early intervention.
  • Regression is missing, and its absence makes one passage land badly. A substantial minority of autistic children, commonly estimated between a fifth and a third, lose language or social engagement between about 12 and 24 months. The brief states that autism takes root in fetal development and that there is zero evidence of later development from postnatal exposures. Both statements are correct, and a parent who watched their child lose words at 18 months will read them as a denial of what they saw. The honest version says both parts: the regression is real and is a recognized developmental pattern in autism, and it was not caused by something external. That timing coincides with the vaccination schedule, which is why the association persists despite studies covering millions of children finding no link. Saying this directly convinces more parents than stating the conclusion alone.
  • Valproate is missing and is the clearest modifiable prenatal factor known. Exposure to sodium valproate in pregnancy, used for epilepsy and bipolar disorder, substantially raises the likelihood of autism and other neurodevelopmental effects, which is why its use in people who could become pregnant is now tightly restricted in many countries. A brief about prenatal contributing factors that omits it is leaving out the one with an actionable clinical response, and nobody should stop an anti-seizure medicine without a specialist conversation.
  • Rett syndrome is listed among conditions closely associated with autism. Since DSM-5 it is classified separately rather than as an autism spectrum disorder, though it shares features. Fragile X syndrome and tuberous sclerosis are correctly placed.
  • Two additions on genetics: heritability estimates from twin studies are around 80 percent, among the highest of any neurodevelopmental condition; and most autism is polygenic, arising from many common variants of small effect, with identifiable single-gene causes and de novo variants accounting for a minority. There is also reasonable evidence that periconceptional folic acid supplementation is associated with lower likelihood, which fits alongside the brief's prenatal health advice.
  • The prematurity threshold is narrower than the evidence. Risk is elevated across preterm birth generally, rising as gestational age falls, rather than only before 26 weeks.
  • Screening could be more specific, since this is the actionable part. Autism screening is recommended at both 18 and 24 months, usually with a parent questionnaire such as the M-CHAT-R with structured follow-up. Two screens are used because development changes between them. A positive screen means referral, not diagnosis.
  • Who gets missed belongs here. Girls are diagnosed later and more often missed, because criteria and tools were built largely on boys. Black and Hispanic children in the United States have historically been diagnosed later and more often misdiagnosed first. Children without intellectual disability are frequently identified only at school age or in adulthood. Prevalence figures and screening performance both reflect these gaps.
  • The early intervention claims need proportion. Support improves communication, daily living skills and family wellbeing, with reasonable evidence. Describing the impact as transformative and as significantly improving long-term independence outruns trials that are often small and rarely followed for long. It also sits uneasily beside the brief's own framing of autism as a variation rather than something to be fixed: autistic adults have been clear that interventions aimed at producing typical-looking behaviour, particularly suppressing stimming and enforcing eye contact, carry costs that older studies did not measure.
  • One practical point worth more than any other here: in the United States, early intervention services under IDEA Part C are available on developmental concern alone, with no autism diagnosis required, and parents can usually refer directly. Families routinely wait a year for an assessment before asking for help they were already entitled to.
  • Everything else in the brief is accurate: autism as a neurodevelopmental condition of social communication differences and restricted or repetitive patterns, rooted in early brain development and genetic architecture rather than preventable; twin and family studies showing genetics as the largest contributor through both inherited variation and de novo mutations; advanced parental age raising likelihood through higher rates of spontaneous mutation in gametes; perinatal complications correlating with increased likelihood; large-scale studies across millions of children finding no link between vaccines, including MMR and thimerosal, and autism, with withholding vaccines putting children at real risk; developmental surveillance of social smiles, name response, babbling and gesturing at routine visits; and early individualized developmental, behavioural, speech and occupational support.

Download the PDF

All source documents